SO+GI scan offers the NIPT blood test at the affordable cost of $420.00* as part of its NIPT package, with results given directly to patient and referring doctor.
(Unlike at other pathology services where results go to the referring doctor only). We can discuss any abnormal results with you in detail.
This is a new technology that has only been available in Australia since late 2012. SO+GI was the first to introduce NIPT to Queensland.
NIPT has been offered at so+gi since November 2012. The test uses advanced genetic testing technology that allows for the detection and comparison of fetal DNA within the mother’s blood sample. This blood test itself does not attract a Medicare rebate but there is a medicare rebate for the ultrasound and consult. so+gi has the most competitive price available in Brisbane and offers this test with comprehensive genetic counselling.
NIPT is a maternal blood test that can be performed from 10 weeks gestation. There are no risks to the baby from this test. Currently, it is the most accurate screening test for Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18) and Patau syndrome (Trisomy 13). NIPT allows for a >99% detection rate for Trisomy 21, a 98% detection rate for Trisomy 18, and 80% detection rate for Trisomy 13. There is a 93-95% detection rate for sex chromosome abnormalities including Turner syndrome and Klinefelters syndrome and >99% detection rate for fetal gender.
NIPT at SO+GI scan is available for IVF pregnancies, including those from donor eggs and can be performed in twin gestations (sex chromosome analysis is not available in twin gestations).This allows women to have more detailed information than ever before. This test has been validated for both high and low risk pregnancies, allowing them to avoid the risk of miscarriage associated with the traditional invasive testing options of CVS and amniocentesis.
NIPT is not currently classified as a diagnostic test, so a positive finding of Trisomy 21, 18 or 13 will require confirmation by traditional invasive testing. Depending on background risk, some women / couples may prefer to have CVS or amniocentesis for complete diagnostic information. NIPT enhances but does not replace the nuchal translucency scan. The combination of a reassuring NIPT result with a normal 12-14 week scan provides the best accuracy for early detection of chromosome anomalies by non-invasive approach.
If the nuchal translucency measurement is >3.5mm or there is a fetal anomaly seen on scan then invasive testing (CVS/amniocentesis) with +/- microarray is offered.
The genetic counsellors and medical specialists at so+gi provide full information and counselling about all of the above options to support your decision-making process.
Contact our service on (07) 3120 4200 or email@example.com for more information, or to make an appointment for NIPT discussion and / or NIPT test.